X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Aventis Pharma with Fresenius Kabi Onco. - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs FRESENIUS KABI ONCO. - Comparison Results

SANOFI INDIA    Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

FRESENIUS KABI ONCO. 
   Change

Fresenius Kabi Oncology is the erstwhile Dabur Pharma, which was incorporated in March 2003. The company is a leading player in oncology in India and the international markets. Fresenius Kabi Oncology operates in the regulated markets namely the US a... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANOFI INDIA FRESENIUS KABI ONCO. SANOFI INDIA/
FRESENIUS KABI ONCO.
 
P/E (TTM) x 37.9 22.1 171.5% View Chart
P/BV x 7.2 3.1 229.9% View Chart
Dividend Yield % 0.5 0.0 -  

Financials

 SANOFI INDIA   FRESENIUS KABI ONCO.
EQUITY SHARE DATA
    SANOFI INDIA
Dec-17
FRESENIUS KABI ONCO.
Mar-13
SANOFI INDIA/
FRESENIUS KABI ONCO.
5-Yr Chart
Click to enlarge
High Rs4,945176 2,809.7%   
Low Rs3,90179 4,969.4%   
Sales per share (Unadj.) Rs1,081.837.7 2,870.6%  
Earnings per share (Unadj.) Rs141.65.1 2,779.3%  
Cash flow per share (Unadj.) Rs185.96.7 2,765.6%  
Dividends per share (Unadj.) Rs33.000-  
Dividend yield (eoy) %0.70-  
Book value per share (Unadj.) Rs868.842.5 2,042.1%  
Shares outstanding (eoy) m23.03158.23 14.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.13.4 121.1%   
Avg P/E ratio x31.225.0 125.1%  
P/CF ratio (eoy) x23.818.9 125.7%  
Price / Book Value ratio x5.13.0 170.2%  
Dividend payout %23.30-   
Avg Mkt Cap Rs m101,86220,135 505.9%   
No. of employees `0003.21.2 281.2%   
Total wages/salary Rs m3,685703 524.0%   
Avg. sales/employee Rs Th7,691.95,176.2 148.6%   
Avg. wages/employee Rs Th1,137.7610.4 186.4%   
Avg. net profit/employee Rs Th1,006.5699.6 143.9%   
INCOME DATA
Net Sales Rs m24,9145,963 417.8%  
Other income Rs m80718 4,483.3%   
Total revenues Rs m25,7215,981 430.0%   
Gross profit Rs m5,3721,430 375.6%  
Depreciation Rs m1,022258 396.3%   
Interest Rs m11-26 -42.3%   
Profit before tax Rs m5,1461,216 423.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-68 0.0%   
Tax Rs m1,886342 551.1%   
Profit after tax Rs m3,260806 404.5%  
Gross profit margin %21.624.0 89.9%  
Effective tax rate %36.628.1 130.3%   
Net profit margin %13.113.5 96.8%  
BALANCE SHEET DATA
Current assets Rs m14,4325,102 282.9%   
Current liabilities Rs m6,0102,385 251.9%   
Net working cap to sales %33.845.6 74.2%  
Current ratio x2.42.1 112.3%  
Inventory Days Days61150 40.6%  
Debtors Days Days28113 25.1%  
Net fixed assets Rs m7,9915,148 155.2%   
Share capital Rs m230158 145.6%   
"Free" reserves Rs m19,7786,556 301.7%   
Net worth Rs m20,0086,732 297.2%   
Long term debt Rs m0952 0.0%   
Total assets Rs m27,77010,388 267.3%  
Interest coverage x468.8-45.8 -1,024.1%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x0.90.6 156.3%   
Return on assets %11.87.5 156.9%  
Return on equity %16.312.0 136.1%  
Return on capital %25.814.6 176.5%  
Exports to sales %074.5 0.0%   
Imports to sales %024.8 0.0%   
Exports (fob) Rs mNA4,441 0.0%   
Imports (cif) Rs mNA1,477 0.0%   
Fx inflow Rs m6,3065,298 119.0%   
Fx outflow Rs m5,2571,772 296.6%   
Net fx Rs m1,0493,525 29.8%   
CASH FLOW
From Operations Rs m4,3511,274 341.5%  
From Investments Rs m-787-1,204 65.4%  
From Financial Activity Rs m-1,884-196 960.7%  
Net Cashflow Rs m1,680-126 -1,330.2%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 60.4 81.0 74.6%  
Indian inst/Mut Fund % 14.4 0.3 4,800.0%  
FIIs % 14.6 9.6 152.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.5 9.1 115.4%  
Shareholders   15,184 42,599 35.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANOFI INDIA With:   NOVARTIS  TORRENT PHARMA  STRIDES PHARMA SCIENCE  WYETH LTD  ABBOTT INDIA  

Compare SANOFI INDIA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Of Oil Prices Hitting New Highs; Jet Airways' Bailout Plan, and Top Stocks in Action Today(Pre-Open)

On Friday, share markets in India traded on a negative note throughout the day and ended marginally lower after a volatile day of trading.

Related Views on News

SANOFI INDIA Announces Quarterly Results (2QFY19); Net Profit Up 2.5% (Quarterly Result Update)

Nov 6, 2018 | Updated on Nov 6, 2018

For the quarter ended September 2018, SANOFI INDIA has posted a net profit of Rs 1 bn (up 2.5% YoY). Sales on the other hand came in at Rs 7 bn (up 11.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA Announces Quarterly Results (1QFY19); Net Profit Up 35.1% (Quarterly Result Update)

Jul 27, 2018 | Updated on Jul 27, 2018

For the quarter ended June 2018, SANOFI INDIA has posted a net profit of Rs 996 m (up 35.1% YoY). Sales on the other hand came in at Rs 7 bn (up 13.8% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA Announces Quarterly Results (4QFY18); Net Profit Up 37.5% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, SANOFI INDIA has posted a net profit of Rs 825 m (up 37.5% YoY). Sales on the other hand came in at Rs 6 bn (up 11.7% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

More Views on News

Most Popular

The RCom Bankruptcy: 5 Lessons for Smallcap Investors(Profit Hunter)

Feb 7, 2019

Managements of companies can create or ruin their fortunes. Why is management quality such an important factor in valuing businesses? Read on to find out...

The One Real Estate Stock to Buy Now(The 5 Minute Wrapup)

Feb 13, 2019

The real estate sector is ready to make a comeback. This is the stock to consider buying.

Here's What the Biggest 'Rebirth of India' Investors are Doing(The 5 Minute Wrapup)

Feb 5, 2019

A roundtable on the 18th of January 2019 had investors with billions of dollars of investment kitty.

How We Pick the Most Profitable Stocks from the Portfolios of Super Investors(The 5 Minute Wrapup)

Feb 8, 2019

This is the trick to following super investors and not losing money.

Small Caps Under Seige: Could This Be A Once-in-a-Decade Wealth Creating Opportunity?(Profit Hunter)

Feb 14, 2019

Don't let the dark clouds hovering over small caps scare you into hiding; it will rain gold as sentiments recover. Indeed, there is a blood bath. And if you are a first time investor, the correction is deep enough to scare you out of markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SANOFI INDIA SHARE PRICE


Feb 15, 2019 (Close)

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SANOFI INDIA - JUBILANT LIFE SCIENCES COMPARISON

COMPARE SANOFI INDIA WITH

MARKET STATS